Agilent Technologies ROE 2010-2025 | A

Current and historical return on equity (ROE) values for Agilent Technologies (A) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Agilent Technologies ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-04-30 $1.17B $6.14B 19.46%
2025-01-31 $1.26B $6.03B 20.95%
2024-10-31 $1.29B $5.90B 21.30%
2024-07-31 $1.41B $5.90B 23.40%
2024-04-30 $1.24B $6.21B 20.87%
2024-01-31 $1.24B $6.19B 21.15%
2023-10-31 $1.24B $5.85B 21.76%
2023-07-31 $1.13B $5.56B 20.37%
2023-04-30 $1.35B $5.78B 24.80%
2023-01-31 $1.32B $5.61B 25.05%
2022-10-31 $1.25B $5.31B 24.26%
2022-07-31 $1.33B $5.09B 25.59%
2022-04-30 $1.26B $5.12B 24.51%
2022-01-31 $1.21B $5.15B 23.75%
2021-10-31 $1.21B $5.39B 24.26%
2021-07-31 $0.99B $4.95B 20.38%
2021-04-30 $0.93B $4.81B 19.01%
2021-01-31 $0.81B $4.80B 16.68%
2020-10-31 $0.72B $4.87B 14.77%
2020-07-31 $0.69B $4.98B 14.29%
2020-04-30 $0.68B $4.77B 14.30%
2020-01-31 $0.76B $4.85B 15.70%
2019-10-31 $1.07B $4.75B 21.79%
2019-07-31 $1.07B $4.75B 22.01%
2019-04-30 $1.12B $5.13B 23.15%
2019-01-31 $1.14B $5.04B 24.27%
2018-10-31 $0.32B $4.57B 6.91%
2018-07-31 $0.30B $4.57B 6.43%
2018-04-30 $0.24B $4.62B 5.10%
2018-01-31 $0.20B $4.53B 4.27%
2017-10-31 $0.68B $4.84B 15.10%
2017-07-31 $0.63B $4.61B 14.44%
2017-04-30 $0.58B $4.38B 13.48%
2017-01-31 $0.51B $4.30B 11.94%
2016-10-31 $0.46B $4.25B 11.00%
2016-07-31 $0.48B $4.35B 11.38%
2016-04-30 $0.46B $4.17B 11.23%
2016-01-31 $0.46B $4.05B 11.14%
2015-10-31 $0.40B $4.17B 9.62%
2015-07-31 $0.28B $4.11B 6.22%
2015-04-30 $0.31B $4.16B 6.47%
2015-01-31 $0.37B $4.24B 7.01%
2014-10-31 $0.50B $5.30B 9.03%
2014-07-31 $0.69B $5.64B 12.58%
2014-04-30 $0.71B $5.63B 13.48%
2014-01-31 $0.74B $5.45B 14.21%
2013-10-31 $0.72B $5.29B 13.96%
2013-07-31 $0.94B $4.79B 18.18%
2013-04-30 $1.01B $5.31B 19.56%
2013-01-31 $1.10B $5.35B 21.89%
2012-10-31 $1.15B $5.19B 23.92%
2012-07-31 $1.02B $4.87B 22.09%
2012-04-30 $1.10B $4.73B 24.89%
2012-01-31 $1.05B $4.50B 24.72%
2011-10-31 $1.01B $4.32B 25.59%
2011-07-31 $1.02B $4.20B 27.55%
2011-04-30 $0.89B $3.96B 26.67%
2011-01-31 $0.80B $3.34B 26.56%
2010-10-31 $0.68B $3.24B 24.26%
2010-07-31 $0.42B $2.81B 15.80%
2010-04-30 $0.19B $2.63B 7.54%
2010-01-31 $-0.02B $2.60B -0.64%
2009-10-31 $-0.03B $2.51B -1.24%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $34.110B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.711B 27.62
Boston Scientific (BSX) United States $154.351B 38.64
Stryker (SYK) United States $149.416B 31.24
EssilorLuxottica (ESLOY) France $132.057B 0.00
Medtronic (MDT) Ireland $115.083B 16.32
Lonza Group Ag (LZAGY) Switzerland $49.624B 0.00
Haleon (HLN) United Kingdom $44.474B 25.39
ResMed (RMD) United States $37.259B 27.99
GE HealthCare Technologies (GEHC) United States $34.090B 16.18
Terumo (TRUMY) Japan $24.459B 31.77
Koninklijke Philips (PHG) Netherlands $23.149B 16.24
Insulet (PODD) United States $20.550B 80.67
Zimmer Biomet Holdings (ZBH) United States $18.570B 11.93
Baxter (BAX) United States $14.641B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.157B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.825B 23.75
Lantheus Holdings (LNTH) United States $5.747B 14.50
Prestige Consumer Healthcare (PBH) United States $3.776B 16.87
Perrigo (PRGO) Ireland $3.768B 9.55
Haemonetics (HAE) United States $3.683B 16.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.395B 28.21
ICU Medical (ICUI) United States $3.220B 23.75
QuidelOrtho (QDEL) United States $1.952B 13.42
LeMaitre Vascular (LMAT) United States $1.900B 42.47
AtriCure (ATRC) United States $1.550B 0.00
Acuren (TIC) United States $1.455B 0.00
Green Thumb Industries (GTBIF) United States $1.374B 30.91
Phibro Animal Health (PAHC) United States $1.278B 16.34
AdaptHealth (AHCO) United States $1.237B 12.56
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.053B 0.00
InMode (INMD) Israel $0.932B 9.39
Kestra Medical Technologies (KMTS) United States $0.792B 0.00
Curaleaf Holdings (CURLF) Canada $0.749B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.680B 0.00
Tilray Brands (TLRY) Canada $0.661B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Evolus (EOLS) United States $0.613B 0.00
CeriBell (CBLL) United States $0.592B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.449B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.337B 0.00
VAREX IMAGING (VREX) United States $0.327B 12.02
Sanuwave Health (SNWV) United States $0.310B 0.00
Cresco Labs (CRLBF) United States $0.306B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.302B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Aurora Cannabis (ACB) Canada $0.257B 76.33
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.249B 11.30
Brainsway (BWAY) Israel $0.231B 61.17
Omeros (OMER) United States $0.230B 0.00
OraSure Technologies (OSUR) United States $0.230B 0.00
Verano Holdings (VRNOF) United States $0.226B 0.00
Biote (BTMD) United States $0.221B 6.22
Canopy Growth (CGC) Canada $0.215B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
High Tide (HITI) Canada $0.195B 0.00
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.184B 15.00
Vireo Growth (VREOF) United States $0.162B 0.00
Exagen (XGN) United States $0.151B 0.00
FitLife Brands (FTLF) United States $0.123B 15.13
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.101B 13.05
MacroGenics (MGNX) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.094B 0.00
Jushi Holdings (JUSHF) United States $0.092B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.040B 54.00
Safety Shot (SHOT) United States $0.040B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.87
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00